Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Tumour-associated proteolytic factors uPA and PAI-1 and survival in totally resected gastric cancer.

× No keyword cloud information.

15 in total

Review 1. Chemotherapy for colorectal cancer.

Authors: S Nicum; R Midgley; D J Kerr
Journal: J R Soc Med Date: 2000-08 Impact factor: 5.344

Review 2. The plasmin cascade and matrix metalloproteinases in non-small cell lung cancer.

Authors: G Cox; W P Steward; K J O'Byrne
Journal: Thorax Date: 1999-02 Impact factor: 9.139

3. The Oral Serine Protease Inhibitor WX-671 - First Experience in Patients with Advanced Head and Neck Carcinoma.

Authors: Jens E Meyer; Carsten Brocks; Hendrik Graefe; Carola Mala; Natalie Thäns; Markus Bürgle; Annette Rempel; Nicole Rotter; Barbara Wollenberg; Stephan Lang
Journal: Breast Care (Basel) Date: 2008-10-16 Impact factor: 2.860

Review 4. Preoperative staging of gastric cancer as precondition for multimodal treatment.

Authors: A Sendler; H J Dittler; H Feussner; H Nekarda; E Bollschweiler; U Fink; H Helmberger; H Höfler; J R Siewert
Journal: World J Surg Date: 1995 Jul-Aug Impact factor: 3.352

5. Cellular distribution and clinical value of urokinase-type plasminogen activator, its receptor, and plasminogen activator inhibitor-2 in esophageal squamous cell carcinoma.

Authors: H Shiomi; Y Eguchi; T Tani; M Kodama; T Hattori
Journal: Am J Pathol Date: 2000-02 Impact factor: 4.307

6. [The prognostic importance of urinase type plasminogen activators (uPA) and plasminogen activator inhibitors (PAI-1) in the primary resection of oral squamous cell carcinoma].

Authors: B Hundsdorfer; H-F Zeilhofer; K P Bock; P Dettmar; M Schmitt; H-H Horch
Journal: Mund Kiefer Gesichtschir Date: 2004-02-06

7. [Comparison of urokinase type plasminogen activators (uPA) and plasminogen activator inhibitors (PAI-1) in primary resection of oral squamous cell carcinoma].

Authors: B Hundsdorfer; H-F Zeilhofer; K P Bock; P Dettmar; M Schmitt; H-H Horch
Journal: Mund Kiefer Gesichtschir Date: 2004-02-06

8. Role of plasminogen activator inhibitor-1 in urokinase's paradoxical in vivo tumor suppressing or promoting effects.

Authors: Yuqi Jing; Krisztina Kovacs; Vittal Kurisetty; Zhijie Jiang; Nick Tsinoremas; Jaime R Merchan
Journal: Mol Cancer Res Date: 2012-08-21 Impact factor: 5.852

9. Antisense inhibition of urokinase reduces spread of human ovarian cancer in mice.

Authors: O Wilhelm; M Schmitt; S Höhl; R Senekowitsch; H Graeff
Journal: Clin Exp Metastasis Date: 1995-07 Impact factor: 5.150

10. Overexpression of SERBP1 (Plasminogen activator inhibitor 1 RNA binding protein) in human breast cancer is correlated with favourable prognosis.

Authors: Nuran Bektas Serce; Andreas Boesl; Irina Klaman; Sonja von Serényi; Erik Noetzel; Michael F Press; Arno Dimmler; Arndt Hartmann; Jalid Sehouli; Ruth Knuechel; Matthias W Beckmann; Peter A Fasching; Edgar Dahl
Journal: BMC Cancer Date: 2012-12-13 Impact factor: 4.430